Cargando…
Comment on “Pre-hospital antiplatelet medication use on COVID-19 disease severity”
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier Inc.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472803/ https://www.ncbi.nlm.nih.gov/pubmed/36163207 http://dx.doi.org/10.1016/j.hrtlng.2022.09.004 |
| _version_ | 1784789371612823552 |
|---|---|
| author | Dhakal, Sandesh |
| author_facet | Dhakal, Sandesh |
| author_sort | Dhakal, Sandesh |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9472803 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94728032022-09-15 Comment on “Pre-hospital antiplatelet medication use on COVID-19 disease severity” Dhakal, Sandesh Heart Lung Letter to the Editor Published by Elsevier Inc. 2023 2022-09-14 /pmc/articles/PMC9472803/ /pubmed/36163207 http://dx.doi.org/10.1016/j.hrtlng.2022.09.004 Text en © 2022 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Dhakal, Sandesh Comment on “Pre-hospital antiplatelet medication use on COVID-19 disease severity” |
| title | Comment on “Pre-hospital antiplatelet medication use on COVID-19 disease severity” |
| title_full | Comment on “Pre-hospital antiplatelet medication use on COVID-19 disease severity” |
| title_fullStr | Comment on “Pre-hospital antiplatelet medication use on COVID-19 disease severity” |
| title_full_unstemmed | Comment on “Pre-hospital antiplatelet medication use on COVID-19 disease severity” |
| title_short | Comment on “Pre-hospital antiplatelet medication use on COVID-19 disease severity” |
| title_sort | comment on “pre-hospital antiplatelet medication use on covid-19 disease severity” |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472803/ https://www.ncbi.nlm.nih.gov/pubmed/36163207 http://dx.doi.org/10.1016/j.hrtlng.2022.09.004 |
| work_keys_str_mv | AT dhakalsandesh commentonprehospitalantiplateletmedicationuseoncovid19diseaseseverity |